Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.49B |
| 2 |
Cloudflare
NET
|
+$1.3B |
| 3 |
Roblox
RBLX
|
+$1.1B |
| 4 |
Wayfair
W
|
+$1.05B |
| 5 |
Microsoft
MSFT
|
+$708M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.83B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.24B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Intuitive Surgical
ISRG
|
+$1.39B |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.18% |
| 2 | Healthcare | 9.88% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Communication Services | 9.1% |
| 5 | Financials | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5026
Cocrystal Pharma
COCP
$15.4M
| $893K | ﹤0.01% |
59,501
-583
| -1% | -$8.86K |
|
5027
Usio Inc
USIO
$76.2M
| $891K | ﹤0.01% |
139,213
+9,733
| +8% | +$60.7K |
|
|
ASPU
5028
DELISTED
ASPEN GROUP, INC.
ASPU
| $891K | ﹤0.01% |
136,734
-270,893
| -66% | -$1.54M |
|
5029
ProShares Trust Short MSCI Emerging Markets
EUM
$9.28M
| $890K | ﹤0.01% |
37,961
+562
| +2% | +$13.5K |
|
5030
California Resources
CRC
$4.73B
| $888K | ﹤0.01% |
29,437
+1,867
| +7% | +$51.3K |
|
5031
Santander
BSBR
$43.2B
| $885K | ﹤0.01% |
112,704
-7,941
| -7% | -$59K |
|
5032
Arbutus Biopharma
ABUS
$924M
| $884K | ﹤0.01% |
291,781
-838,590
| -74% | -$2.6M |
|
5033
Empire State Realty Series ES
ESBA
$1.29B
| $883K | ﹤0.01% |
73,328
-4,200
| -5% | -$49.2K |
|
5034
Neuronetics
STIM
$230M
| $883K | ﹤0.01% |
55,152
-233,295
| -81% | -$3.22M |
|
|
RPT
5035
Rithm Property Trust
RPT
$104M
| $881K | ﹤0.01% |
11,316
+2,234
| +25% | +$165K |
|
|
MFD
5036
DELISTED
Macquarie/First Trust Global Infrastructure/Utilities Dividend & Income Fund
MFD
| $881K | ﹤0.01% |
90,364
+7,043
| +8% | +$69.3K |
|
|
CARM
5037
DELISTED
Carisma Therapeutics
CARM
| $880K | ﹤0.01% |
9,522
+9,253
| +3,440% | +$590K |
|
|
SJT
5038
San Juan Basin Royalty Trust
SJT
$131M
| $880K | ﹤0.01% |
171,260
-12,323
| -7% | -$61.8K |
|
5039
Rafael Holdings
RFL
$103M
| $879K | ﹤0.01% |
17,471
+9,626
| +123% | +$419K |
|
|
AGTC
5040
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $879K | ﹤0.01% |
225,289
+123,550
| +121% | +$512K |
|
5041
Gran Tierra Energy
GTE
$325M
| $877K | ﹤0.01% |
118,622
-9,429
| -7% | -$64.3K |
|
5042
LegalZoom.com
LZ
$963M
| $876K | ﹤0.01% |
+23,166
| New | +$877K |
|
5043
Univest Financial
UVSP
$1.19B
| $876K | ﹤0.01% |
33,206
+24,243
| +270% | +$681K |
|
|
AMBR
5044
Amber International Holding Ltd
AMBR
$124M
| $876K | ﹤0.01% |
7,946
-16,551
| -68% | -$1.93M |
|
|
INFI
5045
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $876K | ﹤0.01% |
293,026
+56,995
| +24% | +$180K |
|
|
DCBO
5046
Docebo
DCBO
$584M
| $875K | ﹤0.01% |
14,848
+5,960
| +67% | +$305K |
|
5047
Bar Harbor Bankshares
BHB
$681M
| $873K | ﹤0.01% |
30,514
+7,526
| +33% | +$222K |
|
5048
Innovative Solutions & Support
ISSC
$412M
| $873K | ﹤0.01% |
139,314
+6,300
| +5% | +$38.2K |
|
5049
Miller Industries
MLR
$645M
| $872K | ﹤0.01% |
22,108
+20,811
| +1,605% | +$887K |
|
|
ICD
5050
DELISTED
Independence Contract Drilling, Inc.
ICD
| $867K | ﹤0.01% |
201,902
+5,514
| +3% | +$20.7K |
|
Similar funds
Morgan Stanley's Q2 2021 Portfolio in Review
As of Q2 2021, Morgan Stanley held 8,036 positions worth $758B, up 11% from $681B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley deployed $26.3B of net new capital in Q2 2021, opening 455 new positions and adding to 4,497 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 49,152,168 shares worth $695M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $6.83B trimmed.
- Morgan Stanley's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 49,152,168 shares worth $695M.
- Morgan Stanley added most to Vanguard Total Bond Market in Q2 2021, an estimated $1.49B increase.
- Morgan Stanley's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.83B.
- Morgan Stanley fully exited RealPage, Inc. in Q2 2021, selling an estimated $193M.
- Morgan Stanley's ten largest holdings make up 15% of its $758B portfolio in Q2 2021.
- Morgan Stanley opened 455 new positions and closed 221 in Q2 2021.
- Morgan Stanley's portfolio value rose 11% quarter-over-quarter to $758B.
Based on Morgan Stanley's 13F filing for Q2 2021, filed 16 Aug 2021.